CochLear (OTCMKTS:CHEOY) Shares Gap Down – Should You Sell?

CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY)’s stock price gapped down prior to trading on Thursday. The stock had previously closed at $50.16, but opened at $45.29. CochLear shares last traded at $45.10, with a volume of 828 shares changing hands.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on CHEOY shares. Royal Bank Of Canada cut shares of CochLear from an “outperform” rating to a “sector perform” rating and set a $117.00 price target on the stock. in a research report on Thursday, July 16th. Canaccord Genuity Group downgraded CochLear from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, August 18th. Jefferies Financial Group lowered CochLear from a “strong-buy” rating to a “hold” rating in a report on Wednesday, July 22nd. Finally, Zacks Research raised CochLear from a “strong sell” rating to a “hold” rating in a research note on Monday, June 22nd. Five research analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $117.00.

CochLear Stock Down 5.5%

The company’s fifty day moving average price is $47.04 and its two-hundred day moving average price is $45.42.

About CochLear

Cochlear Limited is an Australian medical technology company that develops, manufactures and supplies implantable hearing solutions for people with moderate to profound hearing loss. Its products are designed to help restore access to sound for individuals who may not benefit sufficiently from conventional hearing aids.

The company’s product portfolio includes cochlear implants, sound processors, bone-conduction hearing implants and related accessories and services. Cochlear also provides professional support, rehabilitation resources and connectivity solutions for recipients, hearing-health specialists and caregivers.

Founded in 1981 and headquartered in Sydney, Australia, Cochlear traces its origins to research led by Professor Graeme Clark, whose work contributed to the development of the world’s first multichannel cochlear implant.